原文始发于微信公众号(化学音乐文化):S3C5:Risk Management
JanFourman,PhD, EdD,MBA, MSRA
Eli Lilly – Pharma registration for diabetes/endocrine, women/men’s health, neural science, oncology, bone/muscle/joint therapeutic areas – 5 years
Eli Lilly – Pharmacovigilance – 7 years
Eli Lilly – Regulatory Intelligence – 3 Years
Purdue University and Roche Diagnostics – Teaching global pharma development, Africa and US
Consultant for Indiana Technical Assistance Program
Invited conference speaker
扫描左侧二维码,获取视频课;扫描右侧二维码,获取音频课
Risk Evaluation and Mitigation Strategies (REMS)
EU Risk Management Plan
FDA Authority for Risk Management
Biologic Risk Management
Sentinel Initiative
发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权